The division of myelodysplastic syndromes (MDS) into low-risk and high-risk categories guides prognosis and treatment, with patients who have lower-risk disease typically receivin ...

The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...

Investigators assessed sex differences in the risk for major cardiovascular events (MACE+) among patients with anemia of non-dialysis chronic kidney disease (CKD).

Agios Pharmaceuticals said on Wednesday its sickle cell drug met one of its two main goals in a late-stage study of patients aged 16 and older, but failed to show a statistically significant reduction ...

PRNewswire/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay Pharmaceutical Group (DPG), is dedicated to providing patients with rare diseases access to orphan drugs. Medunik ...

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...

Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...

So I did what so many runners do and pushed myself to run through exhaustion. And when that became unsustainable, I shortened my runs, slowed my pace, and walked most hills. Still, I felt terrible.

Each November, we observe National Diabetes Month and engage in discussions surrounding prevention, management and the impact ...

Each November, we observe National Diabetes Month and engage in discussions surrounding prevention, management and the impact of this increasingly common autoimmune disease.

Artificial intelligence is stepping into the fight against cancer — and, according to Fox News senior medical analyst Dr. Marc Siegel, it could be a game-changer. On the Monday episode of "Fox & ...